BioPharma Dive3m
‘The bar has risen’: China’s biotech gains push US companies to adapt
Pharma dealmaking for drugs invented in China is putting pressure on U.S. biotechs to compete harder, according to investors and executives interviewed by BioPharma Dive at the J.P. Morgan Healthcare ...
FDA OKs sales of Zyn nicotine pouches, citing health benefits for adult smokers
Federal health officials are backing the health benefits of nicotine pouches, ruling that Philip Morris International's Zyn ...
What Foods Will Be Impacted by FDA’s Ban on Red Dye No. 3—And What Could Replace It
T he U.S. Food and Drug Administration (FDA) banned the use of Red Dye No. 3 in food and ingested drugs on Wednesday, more ...
US FDA grants first market authorization of nicotine pouches to Zyn
The U.S. Food and Drug Administration authorized the marketing of 20 Zyn products on Thursday, the first such authorization ...
How Can Health Care Startups Cut Through Wellness Misinformation? This Company Has a Plan
With $10 million in new funding, Teal Health co-founder Kara Egan shares how her cervical cancer testing startup intends to reach its first patients.
These Are The Foods Affected By The Red 3 Dye Ban — And How They Can Endanger Your Health
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...